+7 495 640-17-71



Important news

We are pleased to invite you in our stand z4d41, to explore innovations of PCR technology. Reserve a time slot sending request to info@dna-technology.com
We are looking forward to meeting you!


“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. The Panel  Composition included Alpha, Beta SARS-CoV-2 Variants, etc. The correct result was obtained in 100% of cases.


First outbreak of the Candida auris, type of yeast or fungi, has been reported recently in the Texas and Washington, USA (source). This fungus is not dangerous for the people with strong immune system, but can be a big problem for those with the impaired immunity – people with chronic or opportunistic diseases.


All news

New research that was aimed to investigate molecular basis of the vaginal microbiome applying the Femoflor® 16 test system in women with nonspecific colpitis has become available on the website under Study Guides section. As a result of the extensive research, authors have confirmed that the real-time PCR-based Femoflor® 16 test system provides results corresponding to those of conventional microbiology regarding the assessment of the vaginal flora state. For more information on the research summary report click here.


In this publication we offer to review the results of a study conducted under the guidance of Professor Ekaterina Voroshilina, Doctor of Medical Sciences, presented during the international conference ESHRE ’s 37th virtual Annual Meeting 2021 (European Society for Human Reproduction and Embryology).


Dear partners,

“DNA-Technology” will be closed for public holidays from May 1 to May 10, 2021. We will resume our regular work on the May 11. Please, consider this information for your workflow plans.


We are pleased to present a new article "Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections" by A. M. Savicheva with a group of authors from D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology and St. Petersburg State Pediatric Medical University, St. Petersburg.


Dear Partners,

With 2020 a year comes to its end, which is nothing less than a break in history of our planet. The pandemic directly or indirectly affected the entire mankind. In these times, we are blessed and thankful, having you as partners and friends on our side.


Dear colleagues!
We are pleased to announce that we have created a new booklet "Femoflor: brief Introduction", which has collected answers to the most frequently asked clinical questions regarding the diagnosis of reproductive tract infections.
Why do you need Femoflor®, if you have a microscopy? What are the indications for Femoflor®-screen and Femoflor®-16 tests? How to read the report? Is it possible to use Femoflor® for men?


Dear colleagues!
We are glad to announce that our article "Diagnosis of the virus that causes COVID-19 by real-time PCR" by a team of authors (E. V. Goncharova, A. E. Donnikov, V. V. Kadochnikova , S. A. Morozov, M. N. Boldyreva, I. S. Galkina, D. V. Blinov) was published in the journal "Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology". For more information please click the link below.


Dear colleagues!

We are glad to inform you that “DNA-technology” has started the kit production for detection of SARS-CoV-2 and SARS-CoV-like viruses using reverse transcription and real-time polymerase chain reaction(SARS-CoV-2/SARS-CoV). Kit is certified as CE-IVD, certificate # FD 9031-2020 dated 16.04.2020 RU-IVD, certificate # RZN 2020/9948 dated 01.04.2020. The kit meets the requirements of international documents for diagnostics of the coronavirus (Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. Interim guidance. 19 March 2020. WHO).


Dear colleagues!

Meet us at MEDLAB 2020 in Dubai, February 3rd-6th at booth Z5.B48.
MEDLAB is one of the biggest clinical laboratory exhibition and congress, where leading companies are presented, spanning across the Middle East, Asia, East/West Africa, Europe and the US.
If you would like to set appointment with us there, please contact us in advance by email: info@dna-technology.com.